Stay updated with the latest drug-development news, articles, and insights from trusted sources. Explore in-depth coverage and expert analysis on drug-development topics.
Hyderabad, April 6 (RAHNUMA): CuraTeQ Biologics, a subsidiary of Aurobindo Pharma, has announced positive top-line results from its Phase 3 trial of BP11, an investigational biosimilar to Omalizumab (marketed as Xolair). The study met all primary endpoints, demonstrating strong comparability with the reference drug in treating chronic spontaneous urticaria (CSU) at a 300 mg dose. Conducted across 608 patients at nearly 80 sites in Europe and India, the trial showed precise equivalence in itch s ...Read More >
India's biotech ecosystem has also expanded significantly, now comprising over 2,500 startups, around 100 incubators, more than 600 research institutes, and over 200 accredited laboratories India's biotech sector is entering a new phase of global relevance, with the country's bioeconomy expanding from $10 billion in 2014 to $195 billion in 2026 and projected to touch nearly $300 billion by 2033, according to a report by Endiya Partners. The report, India's Biopharma Moment: Perspectives from D ...Read More >
New Delhi, March 31 (SocialNews.XYZ) India's bioeconomy is approaching the $200 billion mark, which is a significant milestone in its evolution with a strong policy push and growing innovation pipeline signalling the next phase of growth, according to a report released on Tuesday. The report by Endiya Partners said that the nation's bioeconomy has expanded sharply from around $10 billion in 2014 to over $195 billion in 2026, now contributing nearly 5 per cent to the GDP. India, long recognised ...Read More >
Mumbai, Oct 31 (SocialNews.XYZ) Actress Deepika Padukone, who has been a strong advocate for mental health awareness, reacted to cricketer Jemimah Rodrigues' recent revelation about battling anxiety. The 'Om Shanti Om' actress, known for openly sharing her own struggles with depression in the past, praised Jemimah for her honesty and courage in speaking up, highlighting the importance of conversations around mental well-being in sports and beyond. Taking to her Instagram Stories, Deepika Paduko ...Read More >
Hyderabad : Helex, a US and India based therapeutics startup developing a new class of targeted medicines for genetic kidney diseases, today announced its oversubscribed $3.5 million Seed round, led by pi Ventures. Others participating in this round include Bluehill Capital, SOSV, and a global syndicate of investors. With this round, Helex has raised over $6 million in total funding to date. With its recent funding, the company will accelerate preclinical development of its lead program, advanc ...Read More >
The investment is part of the company's planned capital expenditure, reflecting strong business momentum, a robust late-stage development pipeline, and increasing demand for scalable capacity across CMC development and manufacturing. Sai Life Sciences Ltd. on Monday, October 27, announced that it is setting up a new research and development (R&D) block for chemical, manufacturing, and controls processing Hyderabad campus. The five-storeyed facility, designed as a green building, is expected to ...Read More >
New Delhi, Oct 16 (PTI) A study has documented an instance where genome sequencing and result interpretation were completed within just four hours, demonstrating the technique's feasibility for routine clinical use. Described in an article published in the New England Journal of Medicine, the time clocked to sequence one human genome surpassed the Guinness World Record of five hours and two minutes, which was achieved by a team from the US' Stanford University on March 16, 2021. Researchers an ...Read More >
MUMBAI, Sept 25 (Reuters) - Eli Lilly (LLY.N), opens new tab plans to bring its experimental oral weight-loss drug orforglipron to India as it sees market potential in the world's most populous nation, a senior executive said on Thursday. "I do think there is promise for products like that (orforpligron) in India, if it does get approved," Winselow Tucker, Lilly India's president said at an event in Mumbai. Tucker, however, did not indicate when Lilly plans to launch the drug. The drugmaker h ...Read More >
While the presence of residual viral fragments is well-documented, it remains uncertain whether live virus continues to exist in some individuals and whether this contributes to long COVID. Approximately 5-10% of individuals infected with COVID-19 experience lingering symptoms for three months or more, a condition known as long COVID. Researchers have explored various biological mechanisms behind this phenomenon, but a perspective article in the Medical Journal of Australia argues that the vir ...Read More >
Stay updated with the latest None news, articles, and insights from trusted sources. Explore in-depth coverage and expert analysis on None topics.